Literature DB >> 7883225

Caffeine phenotyping of cytochrome P4501A2, N-acetyltransferase, and xanthine oxidase in patients with familial adenomatous polyposis.

A D Spigelman1, K C Farmer, S Oliver, K P Nugent, P N Bennett, L J Notarianni, P Dobrocky, R K Phillips.   

Abstract

Patients with familial adenomatous polyposis (FAP) and age and sex matched controls were tested for cytochrome P4501A2 (CYP1A2), N-acetyltransferase, and xanthine oxidase activities using caffeine urinary metabolites as a discriminator. FAP patients showed significant underactivity of N-acetyltransferase (which inactivates some carcinogens) and significant overactivity of CYP1A2 (which activates some carcinogens). Xanthine oxidase activity, which can generate free radicals and cause cellular damage, was significantly increased in the FAP patients. All but one of the FAP patients had undergone colectomy. A separate group of six patients was therefore assessed before and at an average time of eight weeks after colectomy. No effect on enzyme activity was seen. The differences in enzyme activities detected in this study could produce an excess of active carcinogenic metabolites in the bile of FAP patients and contribute to the high risk for intestinal cancer in FAP.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7883225      PMCID: PMC1382412          DOI: 10.1136/gut.36.2.251

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  26 in total

Review 1.  Experimental colon cancer.

Authors:  J T LaMont; T A O'Gorman
Journal:  Gastroenterology       Date:  1978-12       Impact factor: 22.682

2.  Upper gastrointestinal cancer in patients with familial adenomatous polyposis.

Authors:  A D Spigelman; C B Williams; I C Talbot; P Domizio; R K Phillips
Journal:  Lancet       Date:  1989-09-30       Impact factor: 79.321

3.  Variability in caffeine metabolism.

Authors:  D M Grant; B K Tang; W Kalow
Journal:  Clin Pharmacol Ther       Date:  1983-05       Impact factor: 6.875

4.  Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer.

Authors:  R A Cartwright; R W Glashan; H J Rogers; R A Ahmad; D Barham-Hall; E Higgins; M A Kahn
Journal:  Lancet       Date:  1982-10-16       Impact factor: 79.321

5.  Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression.

Authors:  M Blum; D M Grant; W McBride; M Heim; U A Meyer
Journal:  DNA Cell Biol       Date:  1990-04       Impact factor: 3.311

6.  An alternative test for acetylator phenotyping with caffeine.

Authors:  B K Tang; D Kadar; W Kalow
Journal:  Clin Pharmacol Ther       Date:  1987-11       Impact factor: 6.875

7.  Acetylation phenotype in colorectal carcinoma.

Authors:  K F Ilett; B M David; P Detchon; W M Castleden; R Kwa
Journal:  Cancer Res       Date:  1987-03-01       Impact factor: 12.701

8.  Acetylator genotype-dependent expression of arylamine N-acetyltransferase in human colon cytosol from non-cancer and colorectal cancer patients.

Authors:  W G Kirlin; F Ogolla; A F Andrews; A Trinidad; R J Ferguson; T Yerokun; M Mpezo; D W Hein
Journal:  Cancer Res       Date:  1991-01-15       Impact factor: 12.701

Review 9.  Acetylator genotype and arylamine-induced carcinogenesis.

Authors:  D W Hein
Journal:  Biochim Biophys Acta       Date:  1988-08-03

10.  Role of aromatic amine acetyltransferase in human colorectal cancer.

Authors:  N P Lang; D Z Chu; C F Hunter; D C Kendall; T J Flammang; F F Kadlubar
Journal:  Arch Surg       Date:  1986-11
View more
  3 in total

Review 1.  Human colonocyte detoxification.

Authors:  W E Roediger; W Babidge
Journal:  Gut       Date:  1997-12       Impact factor: 23.059

Review 2.  Gastroduodenal lesions in familial adenomatous polyposis.

Authors:  H Kashiwagi; A D Spigelman
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

3.  Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism.

Authors:  Christoph Sachse; Upinder Bhambra; Gillian Smith; Tracy J Lightfoot; Jennifer H Barrett; Jenna Scollay; R Colin Garner; Alan R Boobis; C Roland Wolf; Nigel J Gooderham
Journal:  Br J Clin Pharmacol       Date:  2003-01       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.